The first patient has been treated in a clinical trial of an ophthalmic brachytherapy device for neovascular age-related macular degeneration, Salutaris Medical Devices announced in a press release.
Principal investigator Gregg Kokame, MD, successfully performed the procedure with the SMD-DA device on May 9 in Honolulu.
The prospective, single-arm, open-label study is evaluating the safety and tolerability of the SMD-DA system concomitant with an anti-VEGF treatment regimen in 20 patients; surgeon ease of use will also be determined.
“Our hope is to provide improved outcomes to the growing
Uncategorized